Benitec Biopharma Inc

Benitec Biopharma Inc a developmentstage biotechnology company focuses on the development of novel genetic medicines The company develops DNAdirected RNA interference based therapeutics for chronic and lifethreatening human conditions It is developing BB301 an adenoassociated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and BB103 for the treatment of chronic hepatitis B virus infection The company was incorporated in 1995 and is headquartered in Hayward California